Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myocardial Ischemia, Angina Pectoris”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02007187
What this trial is testing

Danhong Injection in the Treatment of Unstable Angina Pectoris

Who this might be right for
Unstable Angina Pectoris
China Academy of Chinese Medical Sciences 160
Testing effectiveness (Phase 2)Study completedNCT04125732
What this trial is testing

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)

Who this might be right for
Coronary Artery DiseaseIschemiaAngina Refractory+2 more
XyloCor Therapeutics, Inc. 41
Not applicableUnknownNCT02845804
What this trial is testing

Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndrome+1 more
Seoul National University Hospital 1,533
Not applicableStudy completedNCT01956448
What this trial is testing

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®

Who this might be right for
Coronary Artery DiseaseAngina Pectoris
Aarhus University Hospital Skejby 2,800
Not applicableUnknownNCT02247492
What this trial is testing

BIOFLOW-III VIP Russia Registry Orsiro Stent System

Who this might be right for
Coronary Artery Diseases
Biotronik Russia 200
Not applicableUnknownNCT05282511
What this trial is testing

A Multi-Omics Study of Vasospastic Angina

Who this might be right for
Vasospastic Angina
Tongji Hospital 1,200
Testing effectiveness (Phase 2)WithdrawnNCT00825604
What this trial is testing

Quality of Life and Target Achievement After Treatment of Patients With Stable Angina Pectoris

Who this might be right for
Stable Angina Pectoris
Göteborg University
Not applicableActive Not RecruitingNCT03030495
What this trial is testing

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

Who this might be right for
Ischemic Heart Disease
Samsung Medical Center 1,400
Testing effectiveness (Phase 2)UnknownNCT02189499
What this trial is testing

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Who this might be right for
Coronary Artery DiseaseMyocardial Ischemia
Amaranth Medical Inc. 42
Not applicableUnknownNCT02027506
What this trial is testing

Diagnostic Value of Electrocardiographic St-t Wave Changes in Patients With Chronic Stable Angina

Who this might be right for
Ekg Change Ischemia Lateral
Alexandria University 150
Large-scale testing (Phase 3)Study completedNCT00335452
What this trial is testing

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Who this might be right for
Acute Coronary DiseaseAngina Unstable
Sanofi 25,086
Not applicableEnded earlyNCT01665248
What this trial is testing

Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina

Who this might be right for
Coronary Artery Diseases
CHEOL WHAN LEE, MD, PhD. 20
Not applicableStudy completedNCT06845384
What this trial is testing

Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center

Who this might be right for
Аcute Coronary Syndrome
National Medical Research Center for Therapy and Preventive Medicine 555
Not applicableStudy completedNCT02099617
What this trial is testing

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.

Who this might be right for
Stable AnginaSilent Myocardial IschemiaAcute Coronary Syndrome
Ceric Sàrl 1,200
Not applicableStudy completedNCT01086228
What this trial is testing

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Who this might be right for
AnginaChronic Coronary OcclusionStent Thrombosis+6 more
Abbott Medical Devices 2,010
Not applicableStudy completedNCT06065514
What this trial is testing

The Role of Inflammation in Myocardial Infarction

Who this might be right for
Myocardial Infarction
Nicosia General Hospital 100
Not applicableActive Not RecruitingNCT05369182
What this trial is testing

Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)

Who this might be right for
Coronary Microvascular DiseaseCoronary Artery DiseaseIschemic Heart Disease
Samsung Medical Center 1,003
Not applicableStudy completedNCT03648424
What this trial is testing

Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses

Who this might be right for
Type 2 Diabetes Mellitus
Brigham and Women's Hospital 48,262
Not applicableStudy completedNCT00012623
What this trial is testing

Improving Service Delivery Through Access Points

Who this might be right for
HypertensionAnginaDiabetes
US Department of Veterans Affairs 39,481
Not applicableStudy completedNCT00394680
What this trial is testing

Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.

Who this might be right for
Coronary ArteriosclerosisAngina UnstableMyocardial Infarction
Shaare Zedek Medical Center 700
Next Page